Abstract:AIM:Point mutation, one of the commonest gene mutations, is the most important molecular pathogenesis of cancer and chronic infection. The commonest methods for detection of point mutation are based on polymerase chain reaction (PCR). These techniques, however, cannot be used in large scale screening since they are neither accurate nor simple. For this reason, this study established a novel method of competitively differentiated PCR (CD-PCR) for screening point mutation in clinical practice.METHODS:Two competitively differentiated primers for mutant-type and wild-type templates respectively with an identically complemented region in 3' end except for last 2 base pairs and a different non-complemented region in 5' end were designed. Thus, competitive amplification might be carried out at a lower annealing temperature at first, and then differentiated amplification at a higher annealing temperature when primers could not combine with initial templates. The amplification was performed in one-tube. The products of CD-PCR were detected using microplate hybridization assay. CD-PCR was evaluated by detecting G1896A variant of hepatitis B virus (HBV) in form of recombinant plasmids and in sera from patients with hepatitis B, and compared with allele-specific PCR (AS-PCR) and competitive AS-PCR.RESULTS:CD-PCR was successfully established. It could clearly distinguish wild-type and mutant-type plasmid DNA of G1896A variant when the amount of plasmid DNA was between 10(2)-10(8)copies/reaction, while for AS-PCR and competitive AS-PCR, the DNA amount was between 10(2)-10(4)copies/reaction. CD-PCR could detect one copy of G1896A variant among 10-100 copies of wild-type plasmid DNA. The specificity of CD-PCR was higher than those of AS-PCR and competitive AS-PCR in the detection of HBV G1896A variant in sera from patients with hepatitis B. CD-PCR was independent of the amount of HBV DNA in serum. HBV G1896A variant was more often found in HBeAg (-) patients with a lower level of detectable viremia than that with a higher level of detectable viremia (P=0.0192).CONCLUSION:CD-PCR is more specific since it is less influenced by the amount of initial templates and the cross amplification between mutant- and wild-type amplified products. It is also simple and time-saving. Thus, CD-PCR might be useful in routine gene typing and point mutation screening. HBV G1896A or other more important mutations have to be routinely detected in patients with a detectable level of viremia after HBeAg/antibody conversion in clinical practice.

Comparison of PCR-fluorescent-probe assay with DNA sequencing analysis for the detection of Hepatitis B virus YMDD mutation

Analysis of suspicious results of serum HBV DNA detected by fluorescence quantitative PCR

Novel Assay of Competitively Differentiated Polymerase Chain Reaction for Screening Point Mutation of Hepatitis B Virus.

Monitoring of the Emergence of Hepatitis B Virus YMDD Variants by Fluorometric Real-Time PCR

Pyrosequencing for Detection of Drug Resistant Relevant Mutation in the Polymerase Gene of Hepatitis B Virus and Its Clinical Application

Detection and Analysis of Gene Mutation of HBV DNA

Detection of YMDD mutation in HBV polymerase gene region with nested PCR

Detection and RFLP Analysis of the Polymerase Gene Mutation of HBV DNA

Comparing PCR Coupled with Blot-Hybridization and Enzyme Linking to FQ-PCR to Detect HBV.

Multiplex Locked Nucleic Acid Probes for Analysis of Hepatitis B Virus Mutants Using Real-Time PCR

In-Situ Mutation Detection by Magnetic Beads-Probe Based on Single Base Extension and Its Application in Genotyping of Hepatitis B Virus Pre-C Region 1896nt Locus Single Nucleotide Polymorphisms.

A novel assay for detecting the mutation of nucleotide 1758-1777 deletion in core promoter region of hepatitis B virus

Development of A Novel Dna Sequencing Method Not Only for Hepatitis B Virus Genotyping but Also for Drug Resistant Mutation Detection

Application of PCR-RFLP in detection of adefovir dipivoxil resistance-associated mutations in hepatitis B virus

Detection of Anti-Hepatitis B Virus Drug Resistance Mutations Based on Multicolor Melting Curve Analysis

Design and validation of a clinical DNA sequencing assay for drug-resistance genes in hepatitis B virus

Comparison of the Novel Real Time PCR Assay with Sequence Analysis , 27 Reverse Hybridization and Multiplex PCR for Hepatitis B Virus B and C 28 Genotyping

Optimization of Competitively Differentiated Polymerase Chain Reaction in Detection of HBV Basal Core Promoter Mutation

Detection of HBV lamivudine-resistant mutants with the method of PCR-RFLP in combination with PCR clone sequencing

Comparison of Two Real-Time PCR Fluorescence Detection for Hepatitis B Virus DNA

Detection of Hepatitis B Virus M204I Mutation by Quantum Dot-Labeled DNA Probe